Cipla是一家印度制药公司,负责体重管理和CNS治疗,以防治肥胖症,并在全球范围内扩大。 Cipla, an Indian pharma firm, enters weight management and CNS treatments to combat obesity and expand globally.

印度制药公司Cipla正进入印度的体重管理市场, Cipla, an Indian pharmaceutical company, is entering India's weight management market to address rising obesity. 该公司还加强了其在中枢神经系统治疗中的存在,收购了Sanofi的印度CNS产品系列,并计划进一步收购ADHD和Parkinson病。 The company is also boosting its presence in central nervous system treatments, having acquired Sanofi's India CNS product range and planning further acquisitions in ADHD and Parkinson's disease. Cipla旨在成为全球保健领域的领先者,重点是创新和病人护理。 Cipla aims to become a global leader in healthcare, with a focus on innovation and patient care.